Cargando…

May IgG4-related disease be reactivated by SARS-CoV-2 infection?

Detalles Bibliográficos
Autor principal:	Kobak, Senol
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9238317/ https://www.ncbi.nlm.nih.gov/pubmed/35782033 http://dx.doi.org/10.5114/reum.2022.115985

Ejemplares similares

SARS-CoV-2 IgG and IgA antibody response is gender dependent; and IgG antibodies rapidly decline early on
por: Korte, Wolfgang, et al.
Publicado: (2021)

Serum IgG4 levels outperform IgG4/IgG RNA ratio in differential diagnosis of IgG4-related disease
por: Schulte, Lucas A., et al.
Publicado: (2020)

Kinetics and performance of the Abbott architect SARS-CoV-2 IgG antibody assay
por: Hamilton, Fergus, et al.
Publicado: (2020)

Patients with Common Cold Coronaviruses Tested Negative for IgG Antibody to SARS-CoV-2
por: Brecher, Stephen M., et al.
Publicado: (2020)

What is the long‐term clinical significance of anti‐SARS‐CoV‐2‐specific IgG?
por: Alberca, Gabriela Gama Freire, et al.
Publicado: (2020)

SARS-COV-2 IgG and IgM Antibodies in Cancer Patients
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2021)

Comment on “Colchicine may not be effective in COVID-19 infection; it may even be harmful?”
por: Kobak, Senol
Publicado: (2020)

Humoral immune durability of IgG for anti-SARS-CoV-2 in the normal pregnant women in Wuhan, China
por: Ma, Hongwen, et al.
Publicado: (2021)

Evaluation of Specific IgG Antibody in Subjects Who Had Been Previously Infected with SARS-CoV-2
por: Rostami, Soodabeh, et al.
Publicado: (2023)

IgG4-related hypothalamo-hypophysitis
por: Urushida, Yuki, et al.
Publicado: (2021)

Kinetics of SARS-CoV-2 specific antibodies (IgM, IgA, IgG) in non-hospitalized patients four months following infection
por: Orth-Höller, Dorothea, et al.
Publicado: (2021)

Anti-SARS-CoV-2 IgG antibodies in patients with or without SARS-CoV-2 infection after BNT162b2 vaccine booster
por: Salvagno, G.L., et al.
Publicado: (2022)

Disguised aspects of IgG4
por: Dułak, Natalia Aleksandra, et al.
Publicado: (2022)

Reliability and usefulness of a rapid IgM‐IgG antibody test for the diagnosis of SARS-CoV-2 infection: A preliminary report.
por: Spicuzza, Lucia, et al.
Publicado: (2020)

Re-evaluating positive serum samples for SARS-CoV-2-specific IgA and IgG antibodies using an in-house serological assay
por: Cacaci, Margherita, et al.
Publicado: (2021)

Early immunotherapy is highly effective in IgG1/IgG4 positive IgLON5 disease
por: Grüter, Thomas, et al.
Publicado: (2020)

One-year durability of anti-spike IgG to SARS-CoV-2: Preliminary data from the anticrown prospective observational study one year durability of COVID-19 anti-spike IgG
por: Capetti, Amedeo F., et al.
Publicado: (2021)

Decline of SARS-CoV-2-specific IgG, IgM and IgA in convalescent COVID-19 patients within 100 days after hospital discharge
por: Ma, Huan, et al.
Publicado: (2020)

High SARS-CoV-2 IgG seroprevalence among pregnant Cameroun women 14 months after the beginning of the pandemic
por: Mansuy, J.-M., et al.
Publicado: (2022)

Dynamics of anti-SARS-Cov-2 IgM and IgG antibodies among COVID-19 patients
por: Lee, Yu-Lin, et al.
Publicado: (2020)

Development of indigenous IgG ELISA for the detection of anti-SARS-CoV-2 IgG
por: Sapkal, Gajanan, et al.
Publicado: (2020)

SARS-CoV-2 IgG seroprevalence in healthcare workers and other staff at North Bristol NHS Trust: A sociodemographic analysis
por: Jones, Christopher R., et al.
Publicado: (2021)

Clinical Importance of IgG4-related Coronary Periarteritis
por: Ishizaka, Nobukazu
Publicado: (2020)

Impact of MERS-CoV and SARS-CoV-2 Viral Infection on Immunoglobulin-IgG Cross-Reactivity
por: AlKhalifah, Joud Mohammed, et al.
Publicado: (2023)

Persistence of IgG response to SARS-CoV-2
por: Duysburgh, Els, et al.
Publicado: (2021)

Response to the Letter to the Editor Regarding “Serologic Survey of IgG Against SARS-CoV-2 Among Hospital Visitors Without a History of SARS-CoV-2 Infection in Tokyo, 2020–2021”
por: Sanada, Takahiro, et al.
Publicado: (2023)

Serological Detection of SARS-CoV-2 IgG Using Commercially Available Enzyme Immunoassays on Dried Blood Spots Collected from Patients
por: Walker, Gregory J., et al.
Publicado: (2021)

Delayed kinetics of SARS-CoV-2 IgG antibody production in kidney transplant recipients following the third dose of COVID-19 vaccination
por: Matsunami, Masatoshi, et al.
Publicado: (2022)

Diagnostic significance of SARS-CoV-2 IgM positive/IgG negative antibody profile in symptomatic patients with suspected COVID-19 testing negative by RT-PCR
por: Valdivia, Arantxa, et al.
Publicado: (2021)

IgG4-related lung disease. A case report()
por: Ceciaga Elexpuru, Eneko, et al.
Publicado: (2021)

IgG SARS-CoV-2 Antibodies Persist at Least for 10 Months in Patients on Hemodialysis
por: Dudreuilh, Caroline, et al.
Publicado: (2021)

Overlapping between IgG4-RD and Behçet’s Disease
por: Suárez-Díaz, Silvia, et al.
Publicado: (2020)

Glomerulonephritis with monoclonal IgG deposits
por: Gandhi, K., et al.
Publicado: (2015)

Serum IgG4 level predicts COVID-19 related mortality
por: Della-Torre, Emanuel, et al.
Publicado: (2021)

Hypertrophic Pachymeningitis and Interstitial Lung Disease in IgG4-Related Disease
por: Yim, So Hyun, et al.
Publicado: (2022)

Clinical characteristics and persistence of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) IgG antibodies in 4,607 French healthcare workers: Comparison with European countries
por: Delmas, Chantal, et al.
Publicado: (2020)

High Incidence of False-Positive Results in Patients with Acute Infections Other than COVID-19 by the Liaison SARS-CoV-2 Commercial Chemiluminescent Microparticle Immunoassay for Detection of IgG Anti-SARS-CoV-2 Antibodies
por: Boukli, Narjis, et al.
Publicado: (2020)

SARS-CoV-2 viral loads and serum IgA/IgG immune responses in critically ill COVID-19 patients
por: Fourati, Slim, et al.
Publicado: (2020)

418. Comparison of the Abbott SARS-CoV-2 IgG and DiaSorin LIASON SARS-CoV-2 S1/S2 IgG Antibody Assays
por: Schaack, Grace A, et al.
Publicado: (2020)

R: IgG deposition in IgA nephropathy patients
por: Baradaran, Azar
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_gli127msqfv5npj8d7s5jbqer6